Quadrature Capital’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Sell
28,817
-49,473
-63% -$448K ﹤0.01% 1762
2026
Q2
$782K Buy
+78,290
New +$594K 0.01% 826
2025
Q2
– Sell
-37,325
Closed -$138K – 1447
2025
Q1
$138K Buy
+37,325
New +$160K ﹤0.01% 900

Other funds holding SLDB

Quadrature Capital's SLDB Position: Q3 2026 in Review

Quadrature Capital reduced its Solid Biosciences (SLDB) stake by 63% in Q3 2026, selling an estimated $448K and leaving 28,817 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

Quadrature Capital first reported a position in SLDB in Q1 2025 and has held it in 3 quarters since. The position peaked at $782K in Q2 2026. 158 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • Quadrature Capital held 28,817 shares of Solid Biosciences worth $208K as of Q3 2026.
  • Quadrature Capital sold 49,473 Solid Biosciences shares in Q3 2026, an estimated $448K.
  • Solid Biosciences made up ﹤0.01% of Quadrature Capital's portfolio in Q3 2026, its #1762 holding.
  • Quadrature Capital first reported a position in Solid Biosciences in Q1 2025 and has held it in 3 quarters since.
  • Quadrature Capital's Solid Biosciences position peaked at $782K in Q2 2026.
  • 158 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on Quadrature Capital's 13F filing for Q3 2026, filed 13 Nov 2026.